148 related articles for article (PubMed ID: 37269858)
1. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Pe M; Alanya A; Falk RS; Amdal CD; Bjordal K; Chang J; Cislo P; Coens C; Dirven L; Speck RM; Fitzgerald K; Galinsky J; Giesinger JM; Holzner B; Le Cessie S; O'Connor D; Oliver K; Pawar V; Quinten C; Schlichting M; Ren J; Roychoudhury S; Taphoorn MJB; Velikova G; Wintner LM; Griebsch I; Bottomley A;
Lancet Oncol; 2023 Jun; 24(6):e270-e283. PubMed ID: 37269858
[TBL] [Abstract][Full Text] [Related]
2. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Coens C; Pe M; Dueck AC; Sloan J; Basch E; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Devlin N; Dorme L; Flechtner HH; Gotay C; Griebsch I; Groenvold M; King M; Kluetz PG; Koller M; Malone DC; Martinelli F; Mitchell SA; Musoro JZ; O'Connor D; Oliver K; Piault-Louis E; Piccart M; Quinten C; Reijneveld JC; Schürmann C; Smith AW; Soltys KM; Taphoorn MJB; Velikova G; Bottomley A;
Lancet Oncol; 2020 Feb; 21(2):e83-e96. PubMed ID: 32007209
[TBL] [Abstract][Full Text] [Related]
3. Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice.
Liu L; Choi J; Musoro JZ; Sauerbrei W; Amdal CD; Alanya A; Barbachano Y; Cappelleri JC; Falk RS; Fiero MH; Regnault A; Reijneveld JC; Sandin R; Thomassen D; Roychoudhury S; Goetghebeur E; le Cessie S;
Lancet Oncol; 2023 May; 24(5):e197-e206. PubMed ID: 37142381
[TBL] [Abstract][Full Text] [Related]
4. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
Bottomley A; Pe M; Sloan J; Basch E; Bonnetain F; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Greimel E; Griebsch I; Groenvold M; Hamel JF; King M; Kluetz PG; Koller M; Malone DC; Martinelli F; Mitchell SA; Moinpour CM; Musoro J; O'Connor D; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Schürmann C; Smith AW; Soltys KM; Taphoorn MJB; Velikova G; Coens C;
Lancet Oncol; 2016 Nov; 17(11):e510-e514. PubMed ID: 27769798
[TBL] [Abstract][Full Text] [Related]
5. Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Bottomley A; Pe M; Sloan J; Basch E; Bonnetain F; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Greimel E; Griebsch I; Groenvold M; Hamel JF; King M; Kluetz PG; Koller M; Malone DC; Martinelli F; Mitchell SA; Moinpour CM; Musoro JZ; O'Connor D; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Schürmann C; Smith AW; Soltys KM; Sridhara R; Taphoorn MJB; Velikova G; Coens C
Clin Trials; 2018 Dec; 15(6):624-630. PubMed ID: 30141714
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials.
Snyder C; Crossnohere N; King M; Reeve BB; Bottomley A; Calvert M; Thorner E; Wu AW; Brundage M;
Clin Trials; 2022 Jun; 19(3):277-284. PubMed ID: 35094586
[TBL] [Abstract][Full Text] [Related]
8. 15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysis.
Paravathaneni M; Safa H; Joshi V; Tamil MK; Adashek JJ; Ionescu F; Shah S; Chadha JS; Gilbert S; Manley B; Semaan A; Jim HSL; Kalos D; Kim Y; Spiess PE; Chahoud J
EClinicalMedicine; 2024 Feb; 68():102413. PubMed ID: 38273886
[TBL] [Abstract][Full Text] [Related]
9. Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review.
Safa H; Tamil M; Spiess PE; Manley B; Pow-Sang J; Gilbert SM; Safa F; Gonzalez BD; Oswald LB; Semaan A; Diab A; Chahoud J
J Natl Cancer Inst; 2021 May; 113(5):532-542. PubMed ID: 33146385
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
Calvert M; Kyte D; Mercieca-Bebber R; Slade A; Chan AW; King MT; ; Hunn A; Bottomley A; Regnault A; Chan AW; Ells C; O'Connor D; Revicki D; Patrick D; Altman D; Basch E; Velikova G; Price G; Draper H; Blazeby J; Scott J; Coast J; Norquist J; Brown J; Haywood K; Johnson LL; Campbell L; Frank L; von Hildebrand M; Brundage M; Palmer M; Kluetz P; Stephens R; Golub RM; Mitchell S; Groves T
JAMA; 2018 Feb; 319(5):483-494. PubMed ID: 29411037
[TBL] [Abstract][Full Text] [Related]
11. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Patient-Reported Outcomes in an Enhanced Recovery Pathway.
Abola RE; Bennett-Guerrero E; Kent ML; Feldman LS; Fiore JF; Shaw AD; Thacker JKM; Gan TJ; Miller TE; Hedrick TL; McEvoy MD; Mythen MG; Bergamaschi R; Gupta R; Holubar SD; Senagore AJ; Wischmeyer PE; Carli F; Evans DC; Guilbert S; Kozar R; Pryor A; Thiele RH; Everett S; Grocott M;
Anesth Analg; 2018 Jun; 126(6):1874-1882. PubMed ID: 29293180
[TBL] [Abstract][Full Text] [Related]
12. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
Pe M; Dorme L; Coens C; Basch E; Calvert M; Campbell A; Cleeland C; Cocks K; Collette L; Dirven L; Dueck AC; Devlin N; Flechtner HH; Gotay C; Griebsch I; Groenvold M; King M; Koller M; Malone DC; Martinelli F; Mitchell SA; Musoro JZ; Oliver K; Piault-Louis E; Piccart M; Pimentel FL; Quinten C; Reijneveld JC; Sloan J; Velikova G; Bottomley A;
Lancet Oncol; 2018 Sep; 19(9):e459-e469. PubMed ID: 30191850
[TBL] [Abstract][Full Text] [Related]
13. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
Brettschneider C; Lühmann D; Raspe H
GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
[TBL] [Abstract][Full Text] [Related]
14. Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic Review.
Mizusawa J; Ogawa G; Terada M; Ishiki H; Kikawa Y; Kiyota N
Cureus; 2024 May; 16(5):e60804. PubMed ID: 38910767
[TBL] [Abstract][Full Text] [Related]
15. Including patient-reported outcomes and patient-reported resource-use questionnaires in studies.
Bresnahan BW; Rundell SD
Acad Radiol; 2014 Sep; 21(9):1129-37. PubMed ID: 25107865
[TBL] [Abstract][Full Text] [Related]
16. Using the International Classification of Functioning, Disability, and Health to identify outcome domains for a core outcome set for aphasia: a comparison of stakeholder perspectives.
Wallace SJ; Worrall L; Rose T; Le Dorze G
Disabil Rehabil; 2019 Mar; 41(5):564-573. PubMed ID: 29130767
[TBL] [Abstract][Full Text] [Related]
17. Concepts and Instruments for Patient-Reported Outcome Assessment in Celiac Disease: Literature Review and Experts' Perspectives.
Clifford S; Taylor AJ; Gerber M; Devine J; Cho M; Walker R; Stefani I; Fidel S; Drahos J; Leffler DA
Value Health; 2020 Jan; 23(1):104-113. PubMed ID: 31952665
[TBL] [Abstract][Full Text] [Related]
18. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
19. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.
Acquadro C; Berzon R; Dubois D; Leidy NK; Marquis P; Revicki D; Rothman M;
Value Health; 2003; 6(5):522-31. PubMed ID: 14627058
[TBL] [Abstract][Full Text] [Related]
20. Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer.
Joly F; Hilpert F; Okamoto A; Stuart G; Ochiai K; Friedlander M;
Eur J Cancer; 2017 Jun; 78():133-138. PubMed ID: 28448857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
